UK markets closed

Outlook Therapeutics, Inc. (OTLK)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
7.78+0.45 (+6.14%)
At close: 04:00PM EDT
7.62 -0.16 (-2.06%)
After hours: 07:21PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts6665
Avg. Estimate-0.9-0.85-3.28-2.02
Low estimate-1.22-1.22-3.93-3
High estimate-0.6-0.61-2-0.85
Year ago EPS-1.6-1-4.8-3.28
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts6665
Avg. EstimateN/A240k240k13.09M
Low estimateN/AN/AN/AN/A
High estimateN/A1.43M1.43M31.7M
Year ago salesN/AN/AN/A240k
Sales growth (year/est)N/AN/AN/A5,354.20%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-1.03-1.17-1-0.85
Actual EPS-1.6-1-0.8-1.55
Difference-0.570.170.2-0.7
Surprise %-55.30%14.50%20.00%-82.40%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.9-0.85-3.28-2.02
7 days ago-0.9-0.85-3.28-2.02
30 days ago-0.9-0.85-3.28-2.02
60 days ago-1.04-0.96-3.88-2.76
90 days ago-0.05-0.05-0.2-0.14
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesOTLKIndustrySector(s)S&P 500
Current qtr.43.80%N/AN/AN/A
Next qtr.15.00%N/AN/AN/A
Current year31.70%N/AN/AN/A
Next year38.40%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A